GLADIOLUS (FT-4202)
View DetailsSponsor
Sponsor Data Pending
Description
Transfusion dependent Sickle Cell Disease: GLADIOLUS (FT-4202) CCTU - Phase 2 Open-Label Study to Evaluate Safety and Clinical Activity of FT-4202 in Patients with Thalassaemia or Sickle Cell Disease.
Site name
Site name Pending
Site PI
Site PI Pending
Start date
Start Date Pending
End date
End Date Pending
Contact links
uclh.info.redcellnetworkhcc@nhs.net
Hibiscus Etavopivat PK Activator Study
View DetailsSponsor
Sponsor Data Pending
Description
Description Pending
Site name
Imperial College Healthcare NHS Trust
Site PI
Site PI Pending
Start date
Start Date Pending
End date
End Date Pending
Contact links
uclh.info.redcellnetworkhcc@nhs.net
Gene Editing Vertex 141 Study
View DetailsSponsor
Sponsor Data Pending
Description
Description Pending
Site name
Imperial College Healthcare NHS Trust
Site PI
Site PI Pending
Start date
Start Date Pending
End date
End Date Pending
Contact links
uclh.info.redcellnetworkhcc@nhs.net
PNH Pegcetacoplan Study
View DetailsSponsor
Sponsor Data Pending
Description
Description Pending
Site name
Imperial College Healthcare NHS Trust
Site PI
Site PI Pending
Start date
Start Date Pending
End date
End Date Pending
Contact links
uclh.info.redcellnetworkhcc@nhs.net
NIHR BioResource- Rare Disease Arm
View DetailsSponsor
Sponsor Data Pending
Description
Rare Diseases Arm:- Sickle Cell Disorder and Thalassemia.
Site name
UCLH
Site PI
Site PI Pending
Start date
Start Date Pending
End date
End Date Pending
Contact links
uclh.info.redcellnetworkhcc@nhs.net
The Molecular Investigation of Unexplained Anaemias and Relaed Congenital Anaemias
View DetailsSponsor
Sponsor Data Pending
Description
Description Pending
Site name
UCLH
Site PI
Site PI Pending
Start date
Start Date Pending
End date
End Date Pending
Contact links
uclh.info.redcellnetworkhcc@nhs.net
